Skip to Main Content
Insider Trading

Benjamin J. Zeskind Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 2 days, 7 hours ago

Benjamin J. Zeskind has an estimated net worth of at least $13.3 million*, as of Aug. 27, 2025. They own 2.3 million shares of IMRX stock. They have sold 0 shares of IMRX stock since 2021, for an estimated $-243,511.

Benjamin J. Zeskind $IMRX SEC Form 4 Insider Trading

Benjamin J. Zeskind has filed a total of 7 insider trades in $IMRX since 2021. Their most recent trade was a purchase of 2,985 shares, made on Jul 01, 2025. Their largest trade was a purchase of 21,000 shares, made on Jun 18, 2025. We estimate that they now own 2.3 million shares of $IMRX, worth an estimated $13.6 million.



Insider Trading at $IMRX

There have been a total of 62 insider trades reported at $IMRX since 2021, with 1.6 million shares purchased and 1.3 million shares sold. The most active insider traders in $IMRX stock have been Benjamin J. Zeskind, Brett Matthew Hall, and Harold Eugene Brakewood. The most recent trade was a purchase of 3,000 shares reported by DIANA HAUSMAN (None), made on Jul 02, 2025.



History of Insider Stock Trades by Benjamin J. Zeskind

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
IMRX logo IMRX Purchase 2,985 Jul 01, 2025 July 3, 2025, 9:12 a.m.
IMRX logo IMRX Purchase 7,015 Jul 02, 2025 July 3, 2025, 9:12 a.m.
IMRX logo IMRX Purchase 21,000 Jun 18, 2025 June 20, 2025, 9:09 a.m.
IMRX logo IMRX Purchase 20,000 Mar 19, 2024 March 19, 2024, 6:59 p.m.
IMRX logo IMRX Purchase 3,000 Mar 23, 2022 March 24, 2022, 4:39 p.m.
IMRX logo IMRX Purchase 2,083 Sep 13, 2021 Sept. 13, 2021, 8 p.m.
IMRX logo IMRX Purchase 2,098 Aug 03, 2021 Aug. 3, 2021, 8 p.m.




$IMRX Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.